We originally tested the hypothesis that quality sleep can alleviate AD pathology, including Aβ plaque and tau tangle accumulation, with mouse models of AD and FNSS, and found that two FNSS mutations can protect PS19 mice from tauopathy (19), though the underlying mechanism remains unclear. The gene discussed is MAPT; the disease is tauopathy.